ORIGINAL RESEARCH article
Front. Public Health
Sec. Public Health Policy
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1681565
This article is part of the Research TopicAddressing Health Disparities through Global Disease Burden Analysis: From Evidence to Equitable PolicyView all 3 articles
Global burden, inequality, and frontier gaps of autism spectrum disorder disability in adolescents and young adults, 1990–2021: a systematic analysis of the GBD 2021 study
Provisionally accepted- 1Guangzhou University of Chinese Medicine, Guangzhou, China
- 2Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
- 3The Third People's Hospital of Zhuhai, Zhuhai, China
- 4The People's Hospital of Longhua Shenzhen, Shenzhen, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background Autism spectrum disorder (ASD) ranks among the leading causes of years lived with disability in adolescence and young adulthood (AYA), yet global assessments still focus on childhood and seldom examine how national development modifies burden. Methods We analysed Global Burden of Disease 2021 data for 204 countries and territories from 1990–2021. Among AYA aged 15–39 years, we extracted the age-standardised prevalence rate (ASPR) and disability-adjusted life-year rate (ASDR), stratified by sex, five-year age groups and Sociodemographic Index (SDI) quintile. Temporal trends were evaluated using the Estimated Annual Percentage Change (EAPC). Cross-country absolute and relative inequalities were quantified with the Slope Index of Inequality (SII) and Concentration Index (CIX). A half-normal stochastic frontier model defined the minimum attainable ASDR for each SDI level; country-year gaps were calculated as observed minus frontier values. Results From 1990 to 2021, prevalent ASD cases increased from 17.52 to 24.13 million and DALYs from 3.30 to 4.55 million. Despite higher counts, global age-standardised rates changed little: in 2021 the ASPR was 811.67 per 100 000 (95% UI 683.34–952.87) and ASDR 153.00 (95% UI 103.77–215.64); EAPCs were near zero. Males contributed about two-thirds of the burden (rate ratio ≈2.1). Disability rose most at ages 30–39 (+56%). A persistent SDI gradient was observed: high-SDI settings recorded ASPR 1 090.72 and ASDR 205.00 versus 845.15 and 158.57 in low-SDI settings. In 2021, SII was 22.53 (95% UI 12.53–32.53) and CIX 0.04 (95% UI 0.02–0.05). Several high-income economies exceeded the frontier, while Bangladesh, Somalia and Niger lay on or below it—likely reflecting surveillance gaps rather than low burden. Conclusions Absolute ASD disability in AYA has risen mainly from population growth and case detection, not higher per capita risk. A sustained male predominance, a renewed peak at ages 30–39, and minimal progress on inequality show that economic gains alone have not reduced burden. Expanding adult screening, vocational support and community-based interventions, alongside stronger surveillance and parent training in low-SDI settings, is required to narrow global gaps.
Keywords: Autism Spectrum Disorder, Adolescents and young adults, Disability-adjusted life years, Cross-country inequality, Frontier analysis
Received: 07 Aug 2025; Accepted: 15 Sep 2025.
Copyright: © 2025 Lin, Shi, Hao, Xie, Fang, Li, Zhang, Luo and Xue. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Aiguo Xue, xueaiguo@126.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.